Lumexa Imaging Holdings, Inc. Income (Loss) from Equity Method Investments
Lumexa Imaging Holdings, Inc. (LMRI) reported Income (Loss) from Equity Method Investments of $18.62 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-08-13
- Lumexa Imaging Holdings, Inc. income (loss) from equity method investments for the quarter ending 2026-06-30 was $18.62M, a 12.66% increase year-over-year.
- Lumexa Imaging Holdings, Inc. income (loss) from equity method investments for the quarter ending 2026-03-31 was $15.02M, a 1.92% decline year-over-year.
- Lumexa Imaging Holdings, Inc. income (loss) from equity method investments for the quarter ending 2025-06-30 was $16.53M.
- Lumexa Imaging Holdings, Inc. income (loss) from equity method investments for the quarter ending 2025-03-31 was $15.32M.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month |
|---|---|---|
| 2026-06-30 | $18.62M 10-Q · filed 2026-08-13 | $33.64M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $15.02M 10-Q · filed 2026-05-12 | |
| 2025-06-30 | $16.53M 10-Q · filed 2026-08-13 | $31.84M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $15.32M 10-Q · filed 2026-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B |